Ms. Hope S. Mccully, SPL-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 389 Gahagan Rd, Smicksburg, PA 16256 Phone: 724-286-9501 Fax: 724-286-9209 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2011.
A new study confirms the findings of two earlier LSU Health New Orleans studies that the definitive indicator of diabetes control, the HbA1c, is deceptively high in African-American children.
In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, "Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones]," at which determination of the carcinogenicity of cell phones and wireless technologies will be made.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
Northwestern University researchers have developed a new artificial intelligence (A.I.) platform that detects COVID-19 by analyzing X-ray images of the lungs.
› Verified 9 days ago